Ot­su­ka in­vests $88M in­to dig­i­tal meds deal with Pro­teus; Cel­gene amps up re­search pact with Evotec

→ Japan’s Ot­su­ka has hand­ed over an $88 mil­lion pay­ment to Pro­teus Dig­i­tal Health for a col­lab­o­ra­tion on the de­vel­op­ment of dig­i­tal meds. They will be work­ing on the Abil­i­fy Mycite Sys­tem and “joint de­vel­op­ment of an ex­pand­ed port­fo­lio of dig­i­tal med­i­cines con­sist­ing of oth­er ther­a­pies such as atyp­i­cal an­tipsy­chotics used in the treat­ment of se­ri­ous men­tal ill­ness in­te­grat­ed with Pro­teus sen­sors.”

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER